Association between reactive oxygen species and disease activity in chronic hepatitis C

Free Radical Biology and Medicine

Volumn 21, Issue 3, 1996, Pages 291-295

  De Maria, Nicola ^a   Colantoni, Alessandra ^a   Fagiuoli, Stefano ^b   Liu, Guang Jun ^a   Rogers, Brad K ^a   Farinati, Fabio ^b   Van Thiel, David H ^a   Floyd, Roberta ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b Oklahoma Medical Research Foundation ^*

Author keywords

Chronic hepatitis; Free radicals; HCV; Hepatotoxicity; Malondialdehyde; Peroxidation; Protein oxidation

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUTATHIONE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

HEPATITIS C VIRUS;

EID: 0029740935     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00044-5     Document Type: Article

References (16)

1. 1. Davis, G. L.; Lindsay, K.; Albrecht, J.; Bodenheimer, H. C., Jr.; Balart, L. A.; Perrillo, R. P.; Dienstag, J. L. Clinical predictors of response to recombinant Interferon-α treatment in patients with chronic non-A, non-B (hepatitis C). J Viral Hep. 1:55-63; 1994.
2. 2. Camps, J.; Cordoba, J.; Esteban, J. I. Pathophysiology of chronic hepatitis C. In: Miguet, J. P.; Dhumeaux, D. eds. Progress in hepatology. Paris: John Libbey Eurotext: 1993; 1993:63-69.
3. 3. Scheuer, P. J.; Ashrafzadeh, P.; Sherlock, S.; Brown, D.; Dusheiko, G. M. The pathology of hepatitis C. Hepatology 15:567-571; 1992.
4. 4. Van Thiel, D. H.; Friedlander, L.; Fagiuoli, S.; Wright, H. I.; Irish, W.; Gavaler, J. S. Response to Interferon-α therapy is influenced by the iron content of the liver. J. Hepatol. 20:410-415; 1994.
5. 5. Yu, B. P. Cellular defences against damage from reactive oxygen species. Physiol. Rev. 74:139-162; 1991.
6. 6. Prinze, C.; Dubbelman, T. M. A. R.; Van Steveninck, J. Protein damage, induced by small amounts of photodinamically generated singlet oxygen or hydroxyl radicals. Biochem. Biophys. Acta 1038:152-157; 1990.
7. 7. Levine, R. L.; Williams, J. A.; Stadtman, E. R.; Shachter, E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233:334-357; 1994.
8. 8. Farinati, F.; Cardin, R.; De Maria, N.; Della Libera, G.; Marafin, C.; Lecis, E.; Burra, P.; Floreani, A.; Cecchetto, A.; Naccarato, R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 22:449-456; 1995.
9. 9. Smith, P. K.; Krohn, R. I.; Hermanson, G. T.; Mallia, A. K.; Gartner, F. H. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85; 1985.
10. 10. Esterbauer, H.; Cheeseman, K. H. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:407-421; 1990.
11. 11. Shimoda, R.; Nagashima, M.; Sakamoto, M.; Yamaguchi, N.; Hirohashi, S.; Yokota, J.; Kasai, H. Increased formation of oxidative DNA damage 8-hydroxydeoxyguanosine in human livers with chronic hepatitis. Cancer Res. 54:3171-3172; 1994.
12. 12. Di Bisceglie, A. M.; Axiotis, C. A.; Hoofnagle, J. H.; Bacon, B. R. Measurements of iron status in patients with chronic hepatitis. Gastoenterology 102:2108-2113; 1992.
13. 13. Piperno, A.; D'Alba, R.; Roffi, L.; Fargion, S.; Mancia, G.; Fiorelli, G. Relation between interferon response and liver iron stores in chronic hepatitis C. Hepatology 18:133; 1993.
14. 14. Babior, B. M. The respiratory burst of phagocytes. J. Clin. Invest. 73:599-601; 1984.
15. 15. Samuni, A.; Krishna, C. M.; Cook, J.; Black, C. D. W.; Russo, A. On radical production by PMA-stimulated neutrophils as monitored by luminol-amplified chemiluminescence. Free Radic. Biol. Med. 10:305-313; 1991.
16. 16. Desmet, W. J.; Gerber, M.; Hoofnagle, J. H.; Manns, M.; Scheuer, P. J. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1518-1520; 1994.